PreciseDx to Present at the 13th European Breast Cancer Conference
Company to share research on the development of an AI-image analysis platform to advance predictive recurrence models
NEW YORK, November 16, 2022 – PreciseDx, a leading AI company leveraging the analysis of morphology features from histology slides to provide more precise, patient-specific risk information, today announced that it will present at the 13th European Breast Cancer Conference. The poster session, “Development and Validation of a Digital-Artificial Intelligent (AI) Enabled Assay to Predict Early-Stage Breast Cancer Recurrence,” will highlight the results of a novel AI-enabled algorithm, using H&E-stained breast cancer slides and digitized scans, to successfully predict breast cancer recurrence within 6 years of initial diagnosis. The AI-enabled risk algorithm was built using the Morphology Feature Array™ technology from PreciseDx.
WHO: PreciseDx
WHAT: Join PreciseDx for a poster presentation, “Development and Validation of a Digital-Artificial Intelligent (AI) Enabled Assay to Predict Early-Stage Breast Cancer Recurrence,” on PreciseDx’s latest research during the conference’s “Basic Science and Translational Research” session.
The 13th European Breast Cancer Conference, which provides a platform for breast cancer specialists and patients to discuss the multidisciplinary approach to breast cancer care. The in-person conference takes place from November 16-18, 2022.
WHEN: Friday, November 18, 2022, from 9:00am to 2:30pm CEST
WHERE: The Barcelona International Convention Centre (CCIB) in Barcelona, Spain
MEDIA: PreciseDx is available for in-person briefings by request via email to precisedx@0to5.com.
About PreciseDx
PreciseDx is a leading AI company that leverages the analysis of morphology features from histology slides to provide more precise, patient-specific risk information. PreciseDx’s Morphology Feature Array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. To learn more about PreciseDx, visit https://precisedx.ai/